Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

News

      Worldwide Flight Services prepares for Covid-19 vaccine with Project Coldstream

      News
      Cargo handler Worldwide Flight Services (WFS) has launched Project Coldstream to co-ordinate its response to the anticipated global transportation of some 16bn doses of...

      Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, In Patients With Heart Failure

      News
      Amgen, Cytokinetics, Incorporated and Servier announced topline results from GALACTIC-HF, a Phase 3 pivotal clinical trial of omecamtiv mecarbil in patients with heart failure...

      BMS Presents Positive Late-Breaking Data from Phase 3 True North Trial Evaluating Zeposia

      Clinical Trials
      Bristol Myers Squibb announced detailed results from True North, a pivotal, placebo-controlled Phase 3 trial evaluating oral Zeposia (ozanimod) as an induction and maintenance...

      Antengene signs MoU with WuXi Biologics to advance development of innovative oncology medicines

      Drug Development
      Antengene Corporation, a leading innovative biopharmaceutical company, and WuXi Biologics (WuXi Bio) announced that they have signed a strategic cooperation Memorandum of Understanding (MoU)...

      CPhI Annual Report predicts significant market changes in digital adoption, generic consumption

      News
      The second part of the 2020 CPhI Annual Report predicts significant market changes for digital adoption and global generic consumption by 2025. The new...

      Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

      Clinical Trials
      AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...

      Pfizer, BioNTech begin rolling submission to EMA for SARS-COV-2 vaccine candidate BNT162B2

      News
      Pfizer and BioNTech announced the initiation of a rolling submission to the EMA for BNT162b2, the lead candidate from the companies’ vaccine development programme...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.